↓ Skip to main content

Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages

Overview of attention for article published in Stem Cell Research & Therapy, June 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 tweeters

Citations

dimensions_citation
108 Dimensions

Readers on

mendeley
106 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Mesenchymal stem cells ameliorate rhabdomyolysis-induced acute kidney injury via the activation of M2 macrophages
Published in
Stem Cell Research & Therapy, June 2014
DOI 10.1186/scrt469
Pubmed ID
Authors

Yanqiu Geng, Li Zhang, Bo Fu, Jianrong Zhang, Quan Hong, Jie Hu, Diangeng Li, Congjuan Luo, Shaoyuan Cui, Fei Zhu, Xiangmei Chen

Abstract

The mortality of rhabdomyolysis-induced acute kidney injury (AKI) is still high, as there is no effective therapy. It has been shown that bone marrow-derived mesenchymal stem cells (MSCs) can induce M2 macrophages, which mediate MSC protection in other experimental inflammation-related organ injury. This study was designed to investigate the protective effects of macrophage activation in MSC therapy of rhabdomyolysis-induced AKI.

Twitter Demographics

The data shown below were collected from the profiles of 3 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 106 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Germany 1 <1%
Canada 1 <1%
Brazil 1 <1%
Unknown 103 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 22%
Student > Bachelor 17 16%
Researcher 14 13%
Student > Master 10 9%
Student > Postgraduate 9 8%
Other 14 13%
Unknown 19 18%
Readers by discipline Count As %
Medicine and Dentistry 28 26%
Biochemistry, Genetics and Molecular Biology 20 19%
Agricultural and Biological Sciences 12 11%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Immunology and Microbiology 4 4%
Other 9 8%
Unknown 29 27%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 May 2015.
All research outputs
#2,696,861
of 5,104,484 outputs
Outputs from Stem Cell Research & Therapy
#268
of 447 outputs
Outputs of similar age
#91,225
of 180,762 outputs
Outputs of similar age from Stem Cell Research & Therapy
#19
of 27 outputs
Altmetric has tracked 5,104,484 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 447 research outputs from this source. They receive a mean Attention Score of 4.5. This one is in the 28th percentile – i.e., 28% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 180,762 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 27 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.